Clover Corporation (ASX: CLV) — Company Overview, News & Financial Data
Clover Corporation is an Australian company specializing in the refining, encapsulation, and delivery of bioactive functional ingredients for the global nutrition, healthcare, and infant food sectors.
Clover Corporation
Clover Corporation is an Australian company specializing in the refining, encapsulation, and delivery of bioactive functional ingredients for the global nutrition, healthcare, and infant food sectors. Operating primarily through its subsidiary Nu-Mega Ingredients, the company refines tuna and algal oils rich in docosahexaenoic acid (DHA) and omega-3 fatty acids using patented microencapsulation technologies. Its encapsulated powders and oil formulations protect sensitive bioactive nutrients from oxidation and off-flavors, enabling seamless integration into infant formula, pediatric nutrition, dietary supplements, and medical foods. Clover Corporation distributes its specialized nutrient solutions to food and pharmaceutical manufacturers across Australasia, Asia, Europe, and North America.
Snapshot
Operations
Products and/or services of Clover Corporation
- Microencapsulated DHA Powders: Delivery of spray-dried microencapsulated tuna and algal oil powders designed for infant formula and pediatric nutrition products, providing oxidative stability and masking unpleasant marine tastes during long-term shelf storage.
- High-DHA Tuna and Algal Oils: Processing and bulk supply of refined tuna and algae-derived polyunsaturated fatty acid oils high in docosahexaenoic acid for incorporation into liquid medical foods, dietary supplements, and functional food products globally.
- Pediatric and Clinical Lipid Formulations: Production of specialized lipid formulations tailored to deliver essential fatty acids to premature infants and specialized pediatric clinical applications, supporting physiological and neurodevelopmental growth in clinical healthcare settings.
- Microencapsulation Technology Licensing and R&D: Development and licensing of proprietary spray-drying and matrix microencapsulation processing methods to encapsulate sensitive bioactive lipids, vitamins, and minerals for commercial food processing and pharmaceutical manufacturers.
- Nutraceutical and Functional Food Ingredients: Supply of customizable omega-3, omega-6, and bioactive nutrient blends formatted for adult nutritional drinks, dairy products, bakery goods, and health supplements across global consumer healthcare markets.
- Manufacturing Facility Operations: Operation of spray-drying, processing, and quality control facilities in Victoria and Queensland, Australia, providing commercial-scale lipid extraction, microencapsulation, packaging, and global export infrastructure to international regulatory standards.
Clover Corporation executive team
- Mr. Peter J. Davey GAICD, gradDip Bus., MBACEO, MD & Executive Director
- Mr. Andrew G. M. Allibon C.A.CFO & Company Secretary
- Mr. David PierottiDirector of Operations
- Mr. Bassam HallakDirector of Sales & Marketing
- Ms. Anne RoachGeneral Manager of People & Culture